User contributions
Jump to navigation
Jump to search
- 20:04, 3 May 2024 diff hist +3 m Endometrial cancer current
- 19:58, 3 May 2024 diff hist +549 m Classical Hodgkin lymphoma - historical →COPP/ABVD {{#subobject:92a2c8|Regimen=1}} current
- 19:20, 3 May 2024 diff hist +137 m Prostate cancer current
- 18:59, 3 May 2024 diff hist +2,641 m Non-small cell lung cancer, squamous →Carboplatin & Paclitaxel (CP) {{#subobject:c5fbdf|Regimen=1}} current
- 18:54, 3 May 2024 diff hist +2,074 Non-small cell lung cancer, squamous →Carboplatin & Paclitaxel (CP) & Pembrolizumab {{#subobject:1dc8a3|Regimen=1}}
- 18:47, 3 May 2024 diff hist +2,076 m Hepatocellular carcinoma current
- 17:07, 3 May 2024 diff hist +55 m Medulloblastoma →Consolidation current
- 17:00, 3 May 2024 diff hist -24 m HIV-associated lymphoma →CNS therapy, prophylaxis {{#subobject:724xbj|Variant=1}} current
- 16:52, 3 May 2024 diff hist +11 m Ewing sarcoma, pediatric current
- 16:51, 3 May 2024 diff hist -80 m Ewing sarcoma, pediatric →COG AEWS1031 Regimen A
- 16:40, 3 May 2024 diff hist -25 m Burkitt lymphoma current
- 12:39, 3 May 2024 diff hist +523 m PJP Prophylaxis current
- 12:34, 3 May 2024 diff hist +33 m Cancer-related fatigue current
- 12:34, 3 May 2024 diff hist +33 m Cancer-related fatigue
- 12:26, 3 May 2024 diff hist +570 m Antidepressants and other psychiatric medications in cancer care current
- 12:22, 3 May 2024 diff hist +93 m Professional organizations current
- 10:57, 3 May 2024 diff hist +1,139 m Head and neck cancer →Cisplatin & RT {{#subobject:c7061f|Regimen=1}} current
- 10:45, 3 May 2024 diff hist +1,725 m Breast cancer, HER2-positive current
- 10:42, 3 May 2024 diff hist +1,080 m Cholangiocarcinoma current
- 01:26, 2 May 2024 diff hist -14 m Immunotherapy toxicity management current
- 01:26, 2 May 2024 diff hist +15 m Immunotherapy toxicity management →Guidelines
- 01:24, 2 May 2024 diff hist -2,558 m Immunotherapy toxicity management →Guidelines
- 01:04, 2 May 2024 diff hist +108 m Category:Guideline pages current
- 01:04, 2 May 2024 diff hist -8 m NCCN guidelines →Fatigue current
- 01:03, 2 May 2024 diff hist -8 m ESMO guidelines →Palliative care current
- 01:03, 2 May 2024 diff hist +36 N Category:Guideline pages Created page with "Category:General reference pages"
- 01:03, 2 May 2024 diff hist -8 m ASCO guidelines current
- 01:02, 2 May 2024 diff hist +32 m NCCN guidelines
- 01:01, 2 May 2024 diff hist -13 m ESMO guidelines
- 01:00, 2 May 2024 diff hist +2 m ASCO guidelines →Pain
- 01:00, 2 May 2024 diff hist +2 m ASCO guidelines
- 01:00, 2 May 2024 diff hist +28 m ASCO guidelines
- 00:05, 2 May 2024 diff hist +634 m Pyruvate kinase deficiency current
- 20:14, 1 May 2024 diff hist +3 m Ovarian cancer →Carboplatin, Pegylated liposomal doxorubicin, Bevacizumab {{#subobject:a38gbb|Regimen=1}} current
- 15:53, 1 May 2024 diff hist +6 m Nasopharyngeal carcinoma current
- 13:47, 1 May 2024 diff hist -167 m Breast cancer →AC-T {{#subobject:633n67|Regimen=1}} current
- 22:56, 30 April 2024 diff hist +209 m How I Treat →Waldenström macroglobulinemia (WM) current
- 22:54, 30 April 2024 diff hist +751 m Follicular lymphoma →References current
- 19:46, 30 April 2024 diff hist +1,008 m Breast cancer, HER2-positive
- 17:35, 30 April 2024 diff hist +1,912 Multiple myeloma, relapsed-refractory →VTD {{#subobject:96881b|Regimen=1}} current
- 17:27, 30 April 2024 diff hist +14 m Multiple myeloma, relapsed-refractory →Regimen variant #2 {{#subobject:fc94h1|Variant=1}}
- 13:11, 30 April 2024 diff hist 0 m Soft tissue sarcoma →Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}} current
- 13:07, 30 April 2024 diff hist +1,701 m Soft tissue sarcoma →Doxorubicin monotherapy {{#subobject:826f82|Regimen=1}}
- 12:58, 30 April 2024 diff hist +44 m Soft tissue sarcoma →References
- 11:33, 30 April 2024 diff hist +20 m Soft tissue sarcoma →Cisplatin monotherapy {{#subobject:6e93fa|Regimen=1}}
- 11:31, 30 April 2024 diff hist +19 m Desmoid tumor current
- 11:29, 30 April 2024 diff hist -7 m Desmoid tumor →Nirogacestat monotherapy {{#subobject:f3agdc|Regimen=1}}
- 11:27, 30 April 2024 diff hist +86 m Breast cancer, triple negative current
- 11:05, 30 April 2024 diff hist +2 m Breast cancer, triple negative →References
- 11:04, 30 April 2024 diff hist +25 m Breast cancer, triple negative →Carboplatin & Gemcitabine (GCb) {{#subobject:d46b34|Regimen=1}}